ScreenerHero

ATXI Avenue Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · avenuetx.com
0.4776USD-27.64%Mkt Cap: 1.80M $P/E: —

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a smal…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap1.80M USD
Enterprise Value-689.91K USD
Revenue (TTM)0 USD
Gross Profit0 USD
Net Income (TTM)-2.91M USD
Revenue/Share0.00 USD
Last Price0.4776 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.12
PEG—
EV/EBITDA—
EV/Revenue—
P/SInfinity
P/B2.20
EPS (TTM)-0.85
EPS (Forward)-3.14
52W Range
0.150040% of range0.9699
52W High0.9699 USD
52W Low0.1500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-207.19%
ROE-158.79%
ROA-99.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.83M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-35.11%
Net Debt-1.94M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.40
Quick Ratio1.38
Book Value/Sh0.17 USD
Cash/Share0.59 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:75
Split DateApr 26, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.29M
Float2.85M
Insiders13.51%
Institutions3.97%
Short Interest
Short Ratio0.7d
Short % Float2.44%
Short % Out.2.44%
Shares Short51.38K
Short (prev mo.)92.16K
Technical
SMA 500.4246 (+12.5%)
SMA 2000.3746 (+27.5%)
Beta-0.23
S&P 52W Chg16.45%
Avg Vol (30d)4.84K
Avg Vol (10d)5.65K
Technical Indicators
RSI (14)52.0
MACD0.0873
MACD Signal0.0724
MACD Hist.+0.0149
BB Upper0.7790 USD
BB Middle0.4291 USD
BB Lower0.0792 USD
BB Width163.08%
ATR (14)0.0945 USD
Vol Ratio (20d)0.00x